Gore & Associates G.K. in Minato-ku, Tokyo, Japan, announced the first clinical use in Japan of the Gore Excluder thoracoa ...
December 22, 2025—iVascular announced the initiation of the 4-NiVO clinical study, which is evaluating the efficacy and safety of its iNstroke 4 ...
Shape Memory Medical Inc. announced that its Impede embolization plug product family, which previously received CE Mark approv ...
Penumbra announced the publication of a new study that showed that the use of the company’s computer-assisted vacuum thr ...
IceCure Medical Ltd. announced that four abstracts featuring data from independent clinical studies conducted in Spain and ...
Johnson & Johnson MedTech announced that the FDA has approved an expanded indication for the company’s TruFill n-But ...
Gore & Associates announced the first implantation of its investigational Gore Ascending Stent Graft in the ARISE III tria ...
Medtronic announced that results from the company-sponsored In.Pact Admiral drug-coated balloon (DCB) French Quality of Life ( ...
December 10, 2025—Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback